Führungsebene
Unser interkulturelles Executive-Team besteht aus Experten aus Medizin und Technologie, die für Glooko medizinische Innovation und wirtschaftlichen Erfolg in Einklang bringen
Russ Johannesson
Chief Executive Officer
Mark Clements, M.D., Ph.D.
Chief Medical Officer
Mark Beucler
Chief Financial Officer
Prakash Menon
Chief Technology Officer
Ed Marshall
Chief Product Officer
Adam Hameed
President of Connected Care
David Pass
President of Life Sciences
David Conn
Executive Vice President of Partnerships & Alliances
Vorstand
Unserem Vorstand gehören Führungskräfte und Gründer an, die Glooko unterstützen und beraten, sodass wir weltweit führend in den Bereichen Datenmanagement und Telemedizin für Menschen mit Diabetes und chronischen Folgeerkrankungen sind
Charles Boorady
Founder & Managing Partner, Health Catalyst Capital
Simon Chong
Co-Founder and Managing Partner, Georgian Partners
Wende Hutton
General Partner, Canaan Partners
Russ Johannesson
Chief Executive Officer, Glooko
Tracy Bahl
OneOncology, CVS, General Atlantic, Emdeon, UHG
Enrique Conterno
OneOncology, CVS, General Atlantic, Emdeon, UHG
Yogen Dalal
Founder, Glooko
Board Observer
Medizinischer Beirat
Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City
Jerome Fischer, M.D.
Partner, Diabetes and Glandular Disease (DGD) Clinic
Michael Greenfield, M.D.
Endocrinologist, El Camino Hospital
David Kerr, M.D.
Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute
